HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward F. Parker James E. May Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cromartie, R. S. Articles by Bartles, D. M. Search for Related Content PubMed PubMed Citation Articles by Cromartie, R. S., III Articles by Bartles, D. M.

Ann Thorac Surg 1980;30:30-35
© 1980 The Society of Thoracic Surgeons

---

Articles

Carcinoma of the Lung: A Clinical Review

From the Division of Thoracic and Cardiovascular Surgery and the Department of Pathology, the Medical University of South Carolina, Charleston, SC

^* Address reprint requests to Dr. Cromartie, Division of Cardiopulmonary Surgery, Indiana University Medical Center, 1100 W Michigan St, Indianapolis, IN 46223

Records of 702 patients with carcinoma of the lung seen from 1960 through 1970 were reviewed. The efficacy of various diagnostic and therapeutic procedures was assessed. Salient findings were as follows: Biopsy of nonpalpable ipsilateral supraclavicular lymph nodes was positive for carcinoma in 63 of 286 patients (22%). Even more surprising, biopsy of nonpalpable contralateral supraclavicular lymph nodes was positive for carcinoma in 9 of 38 patients (24%). Accordingly, the importance of biopsy of nonpalpable supraclavicular nodes is to be stressed. Squamous cell carcinoma was the most common type, but adenocarcinoma was more common in women and nonsmokers. Among the 702 patients, 48 (6.8%) were nonsmokers. The 5-year survival for 92 patients treated by lobectomy was 21%; the 5-year survival for 77 patients treated by pneumonectomy was 19%; the 5-year survival among 18 patients having resection of the chest wall in addition to resection of the primary lesion was 22%. Of 12 patients with small cell carcinoma of the lung treated by resection, there was 1 5-year survivor. The overall 5-year survival in the 702 patients was 6.6%.

This article has been cited by other articles:

				S. G. Spiro, M. K. Gould, and G. L. Colice Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 149S - 160S. [Abstract] [Full Text] [PDF]

				W. Hamilton and D. Sharp Diagnosis of lung cancer in primary care: a structured review Fam. Pract., December 1, 2004; 21(6): 605 - 611. [Abstract] [Full Text] [PDF]

				M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes Chest, January 1, 2003; 123(2009): 97S - 104S. [Abstract] [Full Text] [PDF]

				R. M. Flores, D. J. Goldstein, R. S. Sung, K. M. Steinglass, S. Weinstein, and J. A. Chabot Transthoracic, Transdiaphragmatic Excision of Simultaneous Lung and Adrenal Lesions Ann. Thorac. Surg., March 1, 1998; 65(3): 833 - 835. [Abstract] [Full Text] [PDF]

				D. E. Van Raemdonck, A. Schneider, and R. J. Ginsberg Surgical treatment for higher stage non-small cell lung cancer Ann. Thorac. Surg., November 1, 1992; 54(5): 999 - 1013. [Abstract] [PDF]